| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACLY
|
ATP citrate lyase
|
|
ACO1
|
aconitase 1, soluble
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
ADA
|
adenosine deaminase
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPPL2
|
alkaline phosphatase, placental-like 2
|
|
AMH
|
anti-Mullerian hormone
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANGPTL6
|
angiopoietin-like 6
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA3
|
annexin A3
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC2
|
apolipoprotein C-II
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP8
|
aquaporin 8
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARG2
|
arginase 2
|
|
ARL4A
|
ADP-ribosylation factor-like 4A
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARSA
|
arylsulfatase A
|
|
ASL
|
argininosuccinate lyase
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
B2M
|
beta-2-microglobulin
|
|
BAGE2
|
B melanoma antigen family, member 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCHE
|
butyrylcholinesterase
|
|
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BRSK2
|
BR serine/threonine kinase 2
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSG
|
basigin (Ok blood group)
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C3
|
complement component 3
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CADPS2
|
Ca++-dependent secretion activator 2
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV3
|
caveolin 3
|
|
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCBE1
|
collagen and calcium binding EGF domains 1
|
|
CCK
|
cholecystokinin
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD209
|
CD209 molecule
|
|
CD274
|
CD274 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD47
|
CD47 molecule
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH23
|
cadherin-related 23
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERKL
|
ceramide kinase-like
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR3
|
complement factor H-related 3
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFL2
|
cofilin 2 (muscle)
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLDN18
|
claudin 18
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLPS
|
colipase, pancreatic
|
|
CMIP
|
c-Maf inducing protein
|
|
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNGB1
|
cyclic nucleotide gated channel beta 1
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRELD1
|
cysteine-rich with EGF-like domains 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGD
|
crystallin, gamma D
|
|
CRYGS
|
crystallin, gamma S
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DAXX
|
death-domain associated protein
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDN
|
dendrin
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DHFR
|
dihydrofolate reductase
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DMD
|
dystrophin
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DYSF
|
dysferlin
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDA
|
ectodysplasin A
|
|
EEFSEC
|
eukaryotic elongation factor, selenocysteine-tRNA-specific
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENAM
|
enamelin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group)
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETF1
|
eukaryotic translation termination factor 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAM60A
|
family with sequence similarity 60, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBL
|
fibrillarin
|
|
FBN1
|
fibrillin 1
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FDX1L
|
ferredoxin 1-like
|
|
FECH
|
ferrochelatase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FHL1
|
four and a half LIM domains 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRMD7
|
FERM domain containing 7
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GALNT12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
|
GALNT13
|
polypeptide N-acetylgalactosaminyltransferase 13
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALNT8
|
polypeptide N-acetylgalactosaminyltransferase 8
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GBGT1
|
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCG
|
glucagon
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GDPD1
|
glycerophosphodiester phosphodiesterase domain containing 1
|
|
GDPD2
|
glycerophosphodiester phosphodiesterase domain containing 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLDC
|
glycine dehydrogenase (decarboxylating)
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRA3
|
glycine receptor, alpha 3
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSPT2
|
G1 to S phase transition 2
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa
|
|
GTF2B
|
general transcription factor IIB
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HDAC2
|
histone deacetylase 2
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H3E
|
histone cluster 1, H3e
|
|
HIST2H2AC
|
histone cluster 2, H2ac
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMX3
|
H6 family homeobox 3
|
|
HNF1A-AS1
|
HNF1A antisense RNA 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HS3ST1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDS
|
iduronate 2-sulfatase
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA21
|
interferon, alpha 21
|
|
IFNG
|
interferon, gamma
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB8
|
integrin, beta 8
|
|
ITM2B
|
integral membrane protein 2B
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK2
|
Janus kinase 2
|
|
JMJD6
|
jumonji domain containing 6
|
|
JUN
|
jun proto-oncogene
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNH5
|
potassium channel, voltage gated eag related subfamily H, member 5
|
|
KCNIP2
|
Kv channel interacting protein 2
|
|
KCNIP4
|
Kv channel interacting protein 4
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KEL
|
Kell blood group, metallo-endopeptidase
|
|
KERA
|
keratocan
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIAA1715
|
KIAA1715
|
|
KIF11
|
kinesin family member 11
|
|
KIF14
|
kinesin family member 14
|
|
KIF21A
|
kinesin family member 21A
|
|
KIF5A
|
kinesin family member 5A
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT12
|
keratin 12, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT8
|
keratin 8, type II
|
|
KRT9
|
keratin 9, type I
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEMD3
|
LEM domain containing 3
|
|
LEO1
|
Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LIMS2
|
LIM and senescent cell antigen-like domains 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LOC344967
|
acyl-CoA thioesterase 7 pseudogene
|
|
LOXHD1
|
lipoxygenase homology domains 1
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRC16A
|
leucine rich repeat containing 16A
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LVRN
|
laeverin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYZ
|
lysozyme
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGEB2
|
melanoma antigen family B2
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase
|
|
MAX
|
MYC associated factor X
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MEP1B
|
meprin A, beta
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAM
|
maltase-glucoamylase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR122
|
microRNA 122
|
|
MIR145
|
microRNA 145
|
|
MIR192
|
microRNA 192
|
|
MIR206
|
microRNA 206
|
|
MIR21
|
microRNA 21
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR29A
|
microRNA 29a
|
|
MIR34B
|
microRNA 34b
|
|
MIR423
|
microRNA 423
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MNS1
|
meiosis-specific nuclear structural 1
|
|
MNT
|
MAX network transcriptional repressor
|
|
MPZ
|
myelin protein zero
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT-TI
|
tRNA
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTCH2
|
mitochondrial carrier 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUT
|
methylmalonyl CoA mutase
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO6
|
myosin VI
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYP11
|
myopia 11 (high grade, autosomal dominant)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT6
|
N-acetyltransferase 6 (GCN5-related)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCSTN
|
nicastrin
|
|
ND1
|
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFRKB
|
nuclear factor related to kappaB binding protein
|
|
NGFR
|
nerve growth factor receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOXO1
|
NADPH oxidase organizer 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORM1
|
orosomucoid 1
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10
|
|
PASK
|
PAS domain containing serine/threonine kinase
|
|
PAX6
|
paired box 6
|
|
PAX9
|
paired box 9
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCM1
|
pericentriolar material 1
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE6A
|
phosphodiesterase 6A, cGMP-specific, rod, alpha
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PGF
|
placental growth factor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PILRA
|
paired immunoglobin-like type 2 receptor alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLIN1
|
perilipin 1
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PMM2
|
phosphomannomutase 2
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNLIP
|
pancreatic lipase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLRMT
|
polymerase (RNA) mitochondrial (DNA directed)
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PPY
|
pancreatic polypeptide
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCI
|
protein kinase C, iota
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRPF39
|
pre-mRNA processing factor 39
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTX3
|
pentraxin 3, long
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYCR1
|
pyrroline-5-carboxylate reductase 1
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RTN3
|
reticulon 3
|
|
RTN4
|
reticulon 4
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SATB1
|
SATB homeobox 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SECISBP2
|
SECIS binding protein 2
|
|
SEMG1
|
semenogelin I
|
|
SEPT4
|
septin 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans)
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIX1
|
SIX homeobox 1
|
|
SIX5
|
SIX homeobox 5
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A6
|
solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMAD7
|
SMAD family member 7
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SMPD4
|
sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3)
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPAST
|
spastin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A3
|
steroid 5 alpha-reductase 3
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRP72
|
signal recognition particle 72kDa
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STH
|
saitohin
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SUDS3
|
suppressor of defective silencing 3 homolog (S. cerevisiae)
|
|
SULF1
|
sulfatase 1
|
|
SULF2
|
sulfatase 2
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAF2
|
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa
|
|
TAGLN
|
transgelin
|
|
TAOK1
|
TAO kinase 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBP
|
TATA box binding protein
|
|
TBX1
|
T-box 1
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF3
|
transcription factor 3
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCN2
|
transcobalamin II
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TDG
|
thymine-DNA glycosylase
|
|
TECTA
|
tectorin alpha
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TEP1
|
telomerase-associated protein 1
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGM1
|
transglutaminase 1
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TJP1
|
tight junction protein 1
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMC1
|
transmembrane channel-like 1
|
|
TMEM59
|
transmembrane protein 59
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNIK
|
TRAF2 and NCK interacting kinase
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPTE
|
transmembrane phosphatase with tensin homology
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTN
|
titin
|
|
TTPA
|
tocopherol (alpha) transfer protein
|
|
TTR
|
transthyretin
|
|
TUBB
|
tubulin, beta class I
|
|
TWF1
|
twinfilin actin binding protein 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBC
|
ubiquitin C
|
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast)
|
|
UROS
|
uroporphyrinogen III synthase
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEZF1
|
vascular endothelial zinc finger 1
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WDR5
|
WD repeat domain 5
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WT1
|
Wilms tumor 1
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XYLB
|
xylulokinase homolog (H. influenzae)
|
|
YBX3
|
Y box binding protein 3
|
|
YTHDC1
|
YTH domain containing 1
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
